A case of psoriasis and atopic dermatitis-like rash induced by interleukin-17 and interleukin-23 inhibitors successfully controlled with upadacitinib

Saved in:
Bibliographic Details
Main Authors: Toshiki Okazaki, MD, Takehiro Takahashi, MD, PhD, Riichiro Sugiura, MD, Ryoko Shimada-Omori, MD, PhD, Yoshihide Asano, MD, PhD
Format: Article
Language:English
Published: Elsevier 2025-09-01
Series:JAAD Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352512625003108
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850070873588891648
author Toshiki Okazaki, MD
Takehiro Takahashi, MD, PhD
Riichiro Sugiura, MD
Ryoko Shimada-Omori, MD, PhD
Yoshihide Asano, MD, PhD
author_facet Toshiki Okazaki, MD
Takehiro Takahashi, MD, PhD
Riichiro Sugiura, MD
Ryoko Shimada-Omori, MD, PhD
Yoshihide Asano, MD, PhD
author_sort Toshiki Okazaki, MD
collection DOAJ
format Article
id doaj-art-ecb7fad6a2c44b68a124f950ee3cac0e
institution DOAJ
issn 2352-5126
language English
publishDate 2025-09-01
publisher Elsevier
record_format Article
series JAAD Case Reports
spelling doaj-art-ecb7fad6a2c44b68a124f950ee3cac0e2025-08-20T02:47:25ZengElsevierJAAD Case Reports2352-51262025-09-0163737610.1016/j.jdcr.2025.06.033A case of psoriasis and atopic dermatitis-like rash induced by interleukin-17 and interleukin-23 inhibitors successfully controlled with upadacitinibToshiki Okazaki, MD0Takehiro Takahashi, MD, PhD1Riichiro Sugiura, MD2Ryoko Shimada-Omori, MD, PhD3Yoshihide Asano, MD, PhD4Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, JapanDepartment of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan; Correspondence to: Takehiro Takahashi, MD, PhD, Department of Dermatology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan.Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan; Department of Dermatology, National Defense Medical College, Saitama, JapanDepartment of Dermatology, Tohoku University Graduate School of Medicine, Sendai, JapanDepartment of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japanhttp://www.sciencedirect.com/science/article/pii/S2352512625003108AD-like rashJanus kinase inhibitorpsoriasisupadacitinib
spellingShingle Toshiki Okazaki, MD
Takehiro Takahashi, MD, PhD
Riichiro Sugiura, MD
Ryoko Shimada-Omori, MD, PhD
Yoshihide Asano, MD, PhD
A case of psoriasis and atopic dermatitis-like rash induced by interleukin-17 and interleukin-23 inhibitors successfully controlled with upadacitinib
JAAD Case Reports
AD-like rash
Janus kinase inhibitor
psoriasis
upadacitinib
title A case of psoriasis and atopic dermatitis-like rash induced by interleukin-17 and interleukin-23 inhibitors successfully controlled with upadacitinib
title_full A case of psoriasis and atopic dermatitis-like rash induced by interleukin-17 and interleukin-23 inhibitors successfully controlled with upadacitinib
title_fullStr A case of psoriasis and atopic dermatitis-like rash induced by interleukin-17 and interleukin-23 inhibitors successfully controlled with upadacitinib
title_full_unstemmed A case of psoriasis and atopic dermatitis-like rash induced by interleukin-17 and interleukin-23 inhibitors successfully controlled with upadacitinib
title_short A case of psoriasis and atopic dermatitis-like rash induced by interleukin-17 and interleukin-23 inhibitors successfully controlled with upadacitinib
title_sort case of psoriasis and atopic dermatitis like rash induced by interleukin 17 and interleukin 23 inhibitors successfully controlled with upadacitinib
topic AD-like rash
Janus kinase inhibitor
psoriasis
upadacitinib
url http://www.sciencedirect.com/science/article/pii/S2352512625003108
work_keys_str_mv AT toshikiokazakimd acaseofpsoriasisandatopicdermatitislikerashinducedbyinterleukin17andinterleukin23inhibitorssuccessfullycontrolledwithupadacitinib
AT takehirotakahashimdphd acaseofpsoriasisandatopicdermatitislikerashinducedbyinterleukin17andinterleukin23inhibitorssuccessfullycontrolledwithupadacitinib
AT riichirosugiuramd acaseofpsoriasisandatopicdermatitislikerashinducedbyinterleukin17andinterleukin23inhibitorssuccessfullycontrolledwithupadacitinib
AT ryokoshimadaomorimdphd acaseofpsoriasisandatopicdermatitislikerashinducedbyinterleukin17andinterleukin23inhibitorssuccessfullycontrolledwithupadacitinib
AT yoshihideasanomdphd acaseofpsoriasisandatopicdermatitislikerashinducedbyinterleukin17andinterleukin23inhibitorssuccessfullycontrolledwithupadacitinib
AT toshikiokazakimd caseofpsoriasisandatopicdermatitislikerashinducedbyinterleukin17andinterleukin23inhibitorssuccessfullycontrolledwithupadacitinib
AT takehirotakahashimdphd caseofpsoriasisandatopicdermatitislikerashinducedbyinterleukin17andinterleukin23inhibitorssuccessfullycontrolledwithupadacitinib
AT riichirosugiuramd caseofpsoriasisandatopicdermatitislikerashinducedbyinterleukin17andinterleukin23inhibitorssuccessfullycontrolledwithupadacitinib
AT ryokoshimadaomorimdphd caseofpsoriasisandatopicdermatitislikerashinducedbyinterleukin17andinterleukin23inhibitorssuccessfullycontrolledwithupadacitinib
AT yoshihideasanomdphd caseofpsoriasisandatopicdermatitislikerashinducedbyinterleukin17andinterleukin23inhibitorssuccessfullycontrolledwithupadacitinib